Crossmark

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries

Crossref DOI link: https://doi.org/10.1136/bmjgh-2020-003006

Published Online: 2020-10-20

Published Print: 2020-10

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Ochalek, Jessica https://orcid.org/0000-0003-0744-1178
Abbas, Kaja https://orcid.org/0000-0003-0563-1576
Claxton, Karl https://orcid.org/0000-0003-2002-4694
Jit, Mark https://orcid.org/0000-0001-6658-8255
Lomas, James https://orcid.org/0000-0002-2478-7018
Funding

Funding for this research was provided by:

Vaccine Impact Modelling Consortium (OPP1157270)

Bill and Melinda Gates Foundation (OPP1165566)
License Information

License valid from 2020-10-20